News Story: Full Text
Sponsored By
Cleveland Clinic Brain Tumor and Neuro-Oncology Center
Please Click On The Above Banner For More Details
Braintumor Website

 

Bristol-Myers’ checkpoint star Opdivo fails a PhIII study for glioblastoma

Al's Comment:

 I did not really expect it to do well by itself. I feel that it may be part of a combination approach with other immune therapies. We are funding such a combination trial now!


Posted on: 04/05/2017

Bristol-Myers’ checkpoint star Opdivo fails a PhIII study for glioblastoma

 


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740